Isabelle Munoz1,2, Paul A Beavis3,4. 1. Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. 2. Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, University of Melbourne, Parkville, Victoria, Australia. 3. Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. paul.beavis@petermac.org. 4. Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, University of Melbourne, Parkville, Victoria, Australia. paul.beavis@petermac.org.
Authors: Frank P B Dubois; Ofer Shapira; Noah F Greenwald; Travis Zack; Jeremiah Wala; Jessica W Tsai; Alexander Crane; Audrey Baguette; Djihad Hadjadj; Ashot S Harutyunyan; Kiran H Kumar; Mirjam Blattner-Johnson; Jayne Vogelzang; Cecilia Sousa; Kyung Shin Kang; Claire Sinai; Dayle K Wang; Prasidda Khadka; Kathleen Lewis; Lan Nguyen; Hayley Malkin; Patricia Ho; Ryan O'Rourke; Shu Zhang; Rose Gold; Davy Deng; Jonathan Serrano; Matija Snuderl; Chris Jones; Karen D Wright; Susan N Chi; Jacques Grill; Claudia L Kleinman; Liliana C Goumnerova; Nada Jabado; David T W Jones; Mark W Kieran; Keith L Ligon; Rameen Beroukhim; Pratiti Bandopadhayay Journal: Nat Cancer Date: 2022-07-04